Patient groups back Gelser Blouin bill to let drug companies fund patient copays for costly drugs

Read More

MarketWatch: War over drug-cost assistance traps sickest patients in the middle

Read More

RealClear Health: How Insurers and PBMs Undermine the Patient-Physician Relationship

Read More

OP-ED: Don’t compound tragic effect of COVID-19 on HIV

Read More

OP-ED: Biden Administration Misses Big Chance to Reduce Prescription Drug Costs

Read More

OP-ED: Washington must make drugs more affordable

Read More

OP-ED: Just How ‘Essential’ Are Your Health Benefits?

Read More

OP-ED: Congress must fix loophole that is costing patients at the pharmacy

Read More

OP-ED: Copay assistance should count as part of patients’ cost sharing for medications

Read More

OP-ED: Should Double Charging Patients for Medication be Legal?

Read More